Review: taking Zantac 150 and Compazine together


Summary

Drug interactions are reported among people who take Zantac 150 and Compazine together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Compazine. It is created by eHealthMe based on reports of 1,314 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zantac 150 and Compazine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 3,880 users)

Compazine

Compazine has active ingredients of prochlorperazine. It is often used in nausea. (latest outcomes from Compazine 12,289 users)

On Jul, 29, 2016

1,314 people who take Zantac 150, Compazine are studied.


Number of reports submitted per year:

Zantac 150 and Compazine drug interactions.

Drug effectiveness over time:

Zantac 150:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Compazine:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zantac 150:
  • female: 20.0% - (1 of 5 people)
  • male: 100.0% - (1 of 1 people)
Compazine:
  • female: 20.0% - (1 of 5 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Zantac 150:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 1 people)
Compazine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • nausea
  • rhinorrhoea
  • small intestinal obstruction
  • hyperbilirubinaemia
  • hypotension
  • pneumonia
  • respiratory failure
  • vomiting
  • mucosal inflammation
1 - 6 months:
  • duodenal ulcer perforation
  • interstitial lung disease
  • pain
  • respiratory failure
  • bacteraemia
  • colitis
  • dizziness
  • flank pain
  • pneumonia
  • urinary retention
6 - 12 months:
  • premature labour
  • drug exposure during pregnancy
  • urinary tract infection
1 - 2 years:
  • thrombotic thrombocytopenic purpura
2 - 5 years:
  • abdominal bloating
  • aphasia - primary progressive
  • apraxia
  • burping
  • confusional state
  • constipation aggravated
  • cyclic vomiting syndrome
  • dysphagia aggravated
  • migraine aggravated
  • tardive dyskinesia
5 - 10 years:
  • angina pectoris
  • asthma
  • cerebrovascular accident
  • myocardial infarction
  • obstructive airways disorder
  • atrial fibrillation
  • anxiety
  • aortic arteriosclerosis
  • aortic valve incompetence
  • depression
10+ years:
  • abdominal bloating
  • aphasia - primary progressive
  • apraxia
  • burping
  • confusional state
  • constipation aggravated
  • cyclic vomiting syndrome
  • dysphagia aggravated
  • migraine aggravated
  • tardive dyskinesia
not specified:
  • nausea
  • pain
  • dyspnoea
  • fatigue
  • anxiety
  • anaemia
  • vomiting
  • bone disorder
  • constipation
  • dizziness

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • anxiety
  • vomiting
  • dyspnoea
  • fall
  • back pain
  • constipation
  • fatigue
  • anaemia
male:
  • nausea
  • fatigue
  • thrombocytopenia
  • haemoglobin decreased
  • chest pain
  • bone disorder
  • cough
  • constipation
  • dizziness
  • anaemia

Most common drug interactions by age *:

10-19:
  • abdominal pain upper
  • arrhythmia
  • back pain - low
  • cardiac myxoma
  • chest pain
  • dizziness
  • headache
  • insomnia
  • leg cramping
  • mood swings
20-29:
  • insomnia
  • cellulitis
  • vomiting
  • anaemia
  • constipation
  • dyspnoea
  • depression
  • nausea
  • asthenia
  • weight decreased
30-39:
  • pain
  • pancytopenia
  • paraesthesia
  • pyrexia
  • vomiting
  • dystonia
  • gastrooesophageal reflux disease
  • depression
  • neutropenia
  • gallbladder disorder
40-49:
  • pain
  • anxiety
  • dyspnoea
  • headache
  • arthralgia
  • nausea
  • oedema peripheral
  • cough
  • asthenia
  • constipation
50-59:
  • pain
  • nausea
  • constipation
  • fall
  • hypoaesthesia
  • decreased appetite
  • dyspnoea
  • anxiety
  • bone pain
  • anaemia
60+:
  • bone disorder
  • nausea
  • pain
  • dyspnoea
  • anxiety
  • diarrhoea
  • fatigue
  • vomiting
  • fall
  • constipation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Compazine?

Can you answer these questions?

More questions for: Zantac 150, Compazine

You may be interested in these reviews

More reviews for: Zantac 150, Compazine

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Compazine (prochlorperazine) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.